Dimethyltrienolone

From WikiMD's WELLNESSPEDIA


Chemical structure of Dimethyltrienolone

Dimethyltrienolone is a potent anabolic steroid that is derived from nandrolone. It is known for its high androgen receptor binding affinity and significant anabolic effects. Dimethyltrienolone is a synthetic androgen and anabolic steroid (AAS) that has been studied for its potential use in medicine and sports.

Chemical Properties[edit]

Dimethyltrienolone is chemically related to trenbolone, another powerful anabolic steroid. It is characterized by the addition of two methyl groups at the 17_ position, which enhances its oral bioavailability and resistance to metabolism. The chemical structure of Dimethyltrienolone is depicted in the adjacent image.

Mechanism of Action[edit]

Dimethyltrienolone exerts its effects by binding to the androgen receptor, which leads to the activation of gene transcription and subsequent protein synthesis. This results in increased muscle mass and strength. The compound is known for its strong anabolic effects, which are significantly greater than those of testosterone.

Medical and Non-Medical Use[edit]

While Dimethyltrienolone has been studied for potential therapeutic applications, such as in the treatment of muscle wasting and osteoporosis, it has not been approved for medical use due to its high potential for hepatotoxicity and other adverse effects. In the realm of sports, it is considered a performance-enhancing drug and is banned by most sporting organizations.

Side Effects[edit]

The use of Dimethyltrienolone is associated with several side effects, primarily due to its potent androgenic activity. These include:

Due to these risks, its use is generally discouraged outside of controlled research settings.

Related Compounds[edit]

Dimethyltrienolone is related to other anabolic steroids such as trenbolone, nandrolone, and methandrostenolone. These compounds share similar mechanisms of action but differ in their potency and side effect profiles.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.